Systems, Apparatus and Methods for Coating the Interior of a Container Using a Photolysis and/or Thermal Chemical Vapor Deposition Process
    1.
    发明申请
    Systems, Apparatus and Methods for Coating the Interior of a Container Using a Photolysis and/or Thermal Chemical Vapor Deposition Process 审中-公开
    使用光解和/或热化学气相沉积工艺涂覆容器内部的系统,设备和方法

    公开(公告)号:US20110186537A1

    公开(公告)日:2011-08-04

    申请号:US13120109

    申请日:2009-09-22

    Abstract: Systems, apparatus and methods are provided to apply barrier and/or lubricant materials onto the interior surface of a container, such systems including a container having a chamber; a gas supply source for supplying monomer gas through a gas inlet duct having a portion extending into the chamber; a photolysis source and/or pyrolyzing surface for photolyzing and/or pyrolyzing at least a portion of the monomer gas to form a reactive gas comprising at least one reactive moiety; optionally a temperature controller for maintaining the interior surface of the container at a temperature which is less than the temperature of the pyrolyzing surface to facilitate deposition and polymerization of the reactive moiety on the interior surface of the container; and an outlet duct at the open end or a second end of the container for removing excess reactive gas from the chamber.

    Abstract translation: 提供系统,装置和方法以将屏障和/或润滑剂材料施加到容器的内表面上,这种系统包括具有腔室的容器; 用于通过具有延伸到所述室中的部分的气体入口管道供应单体气体的气体供应源; 光解源和/或热解表面,用于光解和/或热解至少一部分单体气体以形成包含至少一个反应性部分的反应性气体; 可选地,用于将容器的内表面维持在低于热解表面的温度的温度的温度控制器,以促进反应性部分在容器的内表面上的沉积和聚合; 以及在容器的开口端或第二端处的出口管道,用于从室中去除过量的反应气体。

    Hot-melt sealing glass compositions and devices using the same
    6.
    发明授权
    Hot-melt sealing glass compositions and devices using the same 有权
    热熔密封玻璃组合物及使用其的装置

    公开(公告)号:US08786034B2

    公开(公告)日:2014-07-22

    申请号:US13608022

    申请日:2012-09-10

    Abstract: Hot-melt sealing glass compositions that include one or more glass frits dispersed in a polymeric binder system. The polymeric binder system is a solid at room temperature, but melts at a temperature of from about 35° C. to about 90° C., thereby forming a flowable liquid dispersion that can be applied to a substrate (e.g., a cap wafer and/or a device wafer of a MEMS device) by screen printing. Hot-melt sealing glass compositions according to the invention rapidly re-solidify and adhere to the substrate after being deposited by screen printing. Thus, they do not tend to spread out as much as conventional solvent-based glass frit bonding pastes after screen printing. And, because hot-melt sealing glass compositions according to the invention are not solvent-based systems, they do not need to be force dried after deposition.

    Abstract translation: 包括分散在聚合物粘合剂体系中的一种或多种玻璃料的热熔密封玻璃组合物。 聚合物粘合剂体系在室温下为固体,但在约35℃至约90℃的温度下熔融,由此形成可流动的液体分散体,其可施加到基底(例如盖片和 /或MEMS器件的器件晶片)。 根据本发明的热熔密封玻璃组合物在通过丝网印刷沉积之后快速再固化并附着到基底上。 因此,它们在丝网印刷后不会像常规的溶剂型玻璃料粘合膏一样扩散。 而且,由于根据本发明的热熔密封玻璃组合物不是溶剂型体系,它们在沉积后不需要强力干燥。

    METHODS AND COMPOSITIONS TO TREAT MYOCARDIAL CONDITIONS
    8.
    发明申请
    METHODS AND COMPOSITIONS TO TREAT MYOCARDIAL CONDITIONS 失效
    治疗肌肉条件的方法和组合

    公开(公告)号:US20120219521A1

    公开(公告)日:2012-08-30

    申请号:US13468956

    申请日:2012-05-10

    CPC classification number: A61K9/0019 A61K9/0024 A61K31/7088

    Abstract: Methods, devices, kits and compositions to treat a myocardial infarction. In one embodiment, the method includes the prevention of remodeling of the infarct zone of the ventricle. In other embodiments, the method includes the introduction of structurally reinforcing agents. In other embodiments, agents are introduced into a ventricle to increase compliance of the ventricle. In an alternative embodiment, the prevention of remodeling includes the prevention of thinning of the ventricular infarct zone. In another embodiment, the prevention of remodeling and thinning of the infarct zone involves the cross-linking of collagen and prevention of collagen slipping. In other embodiments, the structurally reinforcing agent may be accompanied by other therapeutic agents. These agents may include but are not limited to pro-fibroblastic and angiogenic agents.

    Abstract translation: 用于治疗心肌梗塞的方法,装置,试剂盒和组合物。 在一个实施例中,该方法包括防止脑室梗死区的重塑。 在其它实施方案中,该方法包括引入结构上增强剂。 在其它实施方案中,将药剂引入心室以增加心室的依从性。 在替代实施例中,预防重塑包括防止心室梗塞区变薄。 在另一个实施方案中,预防梗塞区的重塑和变薄包括胶原蛋白的交联和预防胶原蛋白滑脱。 在其它实施方案中,结构上增强剂可以伴随其它治疗剂。 这些药剂可以包括但不限于前成纤维细胞和血管生成剂。

Patent Agency Ranking